Stay updated on GB5121 in Refractory CNS Lymphoma Clinical Trial

Sign up to get notified when there's something new on the GB5121 in Refractory CNS Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GB5121 in Refractory CNS Lymphoma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Footer revision updated from v3.3.3 to v3.3.4, indicating a minor system update with no impact on study data or user functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:48:28.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    The Locations section was expanded to include new trial sites across the US, Australia, Canada, France, and New Zealand, and the previous site listings were removed. Revision: v3.3.3.
    Difference
    1%
    Check dated 2025-12-23T09:26:55.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Revision updated from v3.3.1 to v3.3.2 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:52:46.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Revision tag updated from v3.2.0 to v3.3.1; no changes to the study details, page layout, or content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.8%
    Check dated 2025-11-24T14:51:22.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The government funding status notice about operating status has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T06:55:10.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    No substantive content changes detected; the page's core details (study design, eligibility criteria, and locations) appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T01:21:08.000Z thumbnail image

Stay in the know with updates to GB5121 in Refractory CNS Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GB5121 in Refractory CNS Lymphoma Clinical Trial page.